EMCDDA Home
  • EN
Search

Table TDI-37. Amphetamines and ecstasy clients entering drug treatment, 2009 or most recent year available [see all tables in this series...]

Part (v) Inpatient clients by secondary drug and primary drug

Secondary drugAmphetaminesMDMA and other derivatives
Opioids48512
Cocaine11617
Cannabis 128337
Alcohol56923
Stimulants (other than cocaine)12015
Hypnotics and sedatives43111
Hallucinogens742
Volatile inhalants241
Other substances 633
Total number of citations3165121

Notes:

 Clients may report one primary drug, but more than one secondary drug 

 Countries providing data are: BE, BG, CZ, DK, IE, GR, FR, LU, HU, NL, AT, RO, SK, FI, SE, UK, HR, TR. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also 'General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2010 — Table TDI by centre type.  

(see the help page for information about formats etc.)

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Thursday, 30 June 2011